ExPASy Proteomics tools
The ExPASy (Expert Protein Analysis System) proteomics server of the Swiss Institute of Bioinformatics (SIB) is dedicated to the analysis of protein sequences and structures and the link above points to their tools page.

National Center for Biotechnology Information Publication Page
PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's. These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.

Press Releases

SPRING 2008
DFCI Impact Spring 2008 Nuclea Biomarkers Drives Study into the Molecular Pathology of Cancer

MAY 2008
NUCLEA BIOMARKERS LAUNCHES NUCLEAREDSOX.COM AS A PROUD SUPPORTER OF THE JIMMY FUND AND AVID FAN OF THE BOSTON REDSOX

04/10/08
NUCLEA BIOMARKERS ANNOUNCES THAT IT HAS RECEIVED A U.S. PATENT ON "KINASE PEPTIDES AND ANTIBODIES"

12/7/07
NUCLEA BIOMARKERS ESTABLISHES RESEARCH COLLABORATION WITH CLARK UNIVERSITY INVOLVING HERMANSKY-PUDLAK SYNDROME

WINTER/07
Nuclea Biomarkers Targets Loda and Chin for Latest Gifts Dana Faber Cancer Institute Impact- Winter 2007 page 4

FALL/07
Nuclea Biomarkers Fuels Cancer Pathology Studies Dana Faber Cancer Institute Impact- Fall 2007 page 4

7/15/07
NUCLEA BIOMARKERS RENEWS RESEARCH COLLABORATION WITH DANA FARBER CANCER INSTITUTE

4/30/07
NUCLEA BIOMARKERS ESTABLISHES RESEARCH COLLABORATION WITH THE JOHNS HOPKINS SCHOOL OF MEDICINE JHSM will conduct research studies for development of TMAs using NCI-60 cell lines

3/1/07
NUCLEA BIOMARKERS ESTABLISHES RESEARCH COLLABORATION WITH DANA FARBER CANCER INSTITUTE CENTER FOR MOLECULAR ONCOLOGIC PATHOLOGY

2/20/07
NUCLEA BIOMARKERS ESTABLISHES RESEARCH COLLABORATION WITH DANA FARBER CANCER INSTITUTE Provides funds for lease of an Applied Biosystems Real Time PCR

11/20/06
Nuclea Biomarkers Announces the Development and Production of TMA Microarrays by Automated Methodology

11/16/06
Massachusetts Alliance for Economic Development (MAED) Announces Nuclea Biomarkers is awarded economic impact award for emerging companies

11/03/06
Nuclea Biomarkers Announces that it has Received a U.S. Design Patent on "Antibody Protein Analysis Chip"

9/27/06
Massachusetts Alliance for Economic Development (MAED) Announces winners for its third annual team massachusetts economic impact awards

06/05/06
Nuclea Biomarkers Announces it has Received a Notice of Allowance for U.S. Design Patent

05/01/06
Nuclea Biomarkers Establishes Research Fellowship in the Laboratory of Dr. Massimo Loda of Dana Farber Cancer Institute

04/10/06
The United Kingdom Notifies Nuclea Biomarkers That Its Design Patent Application Entitled "Antibody Protein Analysis Chip" Has Been Allowed

08/10/05
Nuclea Biomarkers Establishes Research Collaboration with Dana Farber Cancer Institute

In The News

03/08/06 - Berkshire Economic Development Corporation
Biotech firm on its way

About Nuclea Biomarkers

Nuclea Biomarkers, LLC is a biotechnology services company that has developed a novel technology platform to improve greatly the efficiency of drug discovery research.

Using the Company's extensive libraries of genetic, molecular, and outcomes data and data-mining services, research professionals in pharmaceutical and life sciences companies are able to focus time and money on the most promising paths for diagnosing and treating a broad range of diseases.